Actively Recruiting

Phase Not Applicable
Age: 0 - 36Weeks
All Genders
ID07161908

Early Detection and Prevention of Health Complications in Preterm Infants - Controlled Remote Monitoring and Optimization of Oxygen Therapy

Led by Institute of Health Information and Statistics of the Czech Republic · Updated on 2025-09-09

70

Participants Needed

4

Research Sites

13 weeks

Total Duration

On this page

Sponsors

I

Institute of Health Information and Statistics of the Czech Republic

Lead Sponsor

Č

České Budějovice Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to develop and test a national approach for remotely monitoring and optimizing oxygen therapy in premature infants diagnosed with bronchopulmonary dysplasia in the Czech Republic. The goal is to reduce health risks and negative impacts on the child's development and family by improving care for preterm newborns. The project is a prospective, multicenter, interventional pilot involving four perinatology centers. Premature infants with bronchopulmonary dysplasia who require low-flow nasal cannulas for oxygen will be included. Their oxygen therapy will be managed remotely using specialized pulse oximeters that continuously monitor oxygen saturation. Treatment adjustments will follow established protocols to safely and earlier reduce oxygen therapy, including tests involving oxygen flow reduction and overnight monitoring. The project is supported by the European Social Fund and the Czech Republic government. Participants will be closely monitored from enrollment until four weeks after stopping home oxygen therapy. Researchers will track oxygen saturation levels continuously and assess the duration of oxygen therapy and the number of therapy failures before termination. The study includes remote monitoring, data collection, and adherence to protocols to optimize care and ensure safety throughout the process.

CONDITIONS

Brief Title

Controlled Remote Monitoring and Optimization of Oxygen Therapy in Preterm Infants

Who Can Participate

Age: 0 - 36Weeks
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Infants born before 31 weeks and 6 days of gestation
  • Signed consent for participation and processing of personal data
  • Diagnosed with bronchopulmonary dysplasia
  • Receiving oxygen therapy via low-flow nasal cannulas
Not Eligible

You will not qualify if you...

  • No signed consent for participation or processing of personal data
  • Diagnosed with other conditions causing high risk of long-term low oxygen, such as major heart defects, brain development disorders, genetic diseases causing breathing problems, central apneas, or severe early obstructive sleep apnea
  • Having other chronic respiratory diseases besides bronchopulmonary dysplasia, like cystic fibrosis or chronic aspiration
  • Insufficient therapy through long-term home oxygen
  • Having a tracheostomy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - From enrollment to 4 weeks after discontinuation of home oxygen therapy

Participants receive controlled remote oxygen therapy with continuous pulse oximeter monitoring to optimize and safely reduce oxygen levels at home.

Continuous remote monitoring with pulse oximeter and occasional hospital/home assessments during oxygen flow adjustments

Follow-up

Duration - 4 weeks after discontinuation of oxygen therapy

Participants are monitored for 4 weeks after complete weaning from oxygen supply to ensure stable oxygen levels and health.

Remote monitoring and periodic assessments as needed

Trial Site Locations

Total: 4 locations

1

České Budějovice Hospital

České Budějovice, Czech Republic, Czechia

Actively Recruiting

2

University Hospital Olomouc

Olomouc, Czech Republic, Czechia

Actively Recruiting

3

General University Hospital

Prague, Czech Republic, Czechia

Actively Recruiting

4

Institute for the Care of Mother and Child

Prague, Czech Republic, Czechia

Actively Recruiting

Loading map...

Research Team

D

Daniela Dokoupilová, MSc

L

Lucie Mandelová, Ph.D.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Similar Trials

129Xenon MR Imaging and Spectroscopy Response to Sotatercept...

Pulmonary Hypertension

Actively Recruiting

1 location

An Open-Label, Phase 2 Study Evaluating the Safety of Moslic...

Pulmonary Hypertension

Actively Recruiting

1 location

A Phase 2, Double-blind, Randomized, Placebo-Controlled Stud...

Pulmonary Hypertension

Actively Recruiting

86 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here